Comparison of Functioning, Quality of Life, and Cognition between Lithium and Sodium Valproate Combination Therapy and Sodium Valproate Monotherapy in Euthymic Bipolar Patients: A Cross-sectional Study

Introduction: The combination of lithium and valproate is the most recommended treatment for relapse prevention in Bipolar Affective Disorder (BPAD) after the failure of monotherapy. If it is proven that functioning, quality of life and cognitive functioning in bipolar patients on a sodium valproate...

Full description

Saved in:
Bibliographic Details
Main Authors: M Ashwini, R Jhamuna, V Jaikumar
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2025-01-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/20524/74880_CE[Ra1]_F(SHU)_QC(AN_OM)_PF1(JY_SS)_PFA(IS)_PB(JY_IS)_PN(IS).pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832590551778590720
author M Ashwini
R Jhamuna
V Jaikumar
author_facet M Ashwini
R Jhamuna
V Jaikumar
author_sort M Ashwini
collection DOAJ
description Introduction: The combination of lithium and valproate is the most recommended treatment for relapse prevention in Bipolar Affective Disorder (BPAD) after the failure of monotherapy. If it is proven that functioning, quality of life and cognitive functioning in bipolar patients on a sodium valproate and lithium combination are better than those on valproate monotherapy, this could further encourage the use of combination therapy. Aim: To compare the functioning, quality of life and cognitive functioning of euthymic bipolar patients on lithium and sodium valproate combination therapy with those on sodium valproate monotherapy. Materials and Methods: The present hospital-based cross-sectional study was conducted in the Outpatient Department, Institute of Mental Health, Madras Medical College, Chennai, Tamil Nadu, India, from March 2017 to July 2017. A total of 80 patients were included in the study. Forty euthymic bipolar disorder patients on a lithium and sodium valproate combination for at least a year were chosen as group 1. Forty euthymic bipolar patients on sodium valproate monotherapy for at least a year were chosen as group 2. Socio-demographic details and clinical characteristics of both groups were collected. The Global Assessment of Functioning (GAF) scale and the World Health Organisation Quality of Life Brief (WHOQoL-BREF) version scale were applied to both groups. Cognitive assessment using the Frontal Assessment Battery (FAB), Trail Making Test-A (TMT-A) and Trail Making Test-B (TMT-B) was conducted. Statistical analysis was performed using International Business Machines (IBM) Statistical Package for Social Sciences (SPSS) software version 20.0. An independent t-test was used to compare quality of life and cognitive variables, as well as, the number of episodes post-treatment between the two groups. A Chi-square test was used to compare functioning between the two groups. Results: The mean±Standard Deviation (SD) age of onset in group 1 was 26.73±5.77 years and in group 2 was 27.03±6.49 years. There were 22 (55%) males and 18 (45) females in group 1 and, 20 (50) males and 20 (50) females in group 2. There were no statistical differences in socio-demographic characteristics between both groups (p-value>0.05). Functioning and quality of life were significantly better in the combination therapy group (p-value ≤0.01). Cognitive variables like FAB score, and time taken to complete TMT-A and TMT-B in seconds showed no significant differences (p-value>0.05). By independent t-test, the reduction in episodes of bipolar illness after treatment was found to be greater in group 1 (p-value=0.006). Conclusion: The functioning, quality of life and effectiveness of treatment for those euthymic bipolar patients on lithium and sodium valproate combination therapy were found to be better than those on valproate monotherapy alone. There was no significant change in cognitive functioning between the two groups.
format Article
id doaj-art-97b92bdfe6024bf2aa44bdf5b6f7f5c7
institution Kabale University
issn 2249-782X
0973-709X
language English
publishDate 2025-01-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj-art-97b92bdfe6024bf2aa44bdf5b6f7f5c72025-01-23T12:19:40ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2025-01-011901010610.7860/JCDR/2025/74880.20524Comparison of Functioning, Quality of Life, and Cognition between Lithium and Sodium Valproate Combination Therapy and Sodium Valproate Monotherapy in Euthymic Bipolar Patients: A Cross-sectional StudyM Ashwini0R Jhamuna1V Jaikumar2Senior Resident, Department of Psychiatry, ACS Medical College and Hospital, Chennai, Tamil Nadu, India.Senior Resident, Department of Psychiatry, ACS Medical College and Hospital, Chennai, Tamil Nadu, India.Associate Professor, Department of Psychiatry, KAPV Medical College, Chennai, Tamil Nadu, India.Introduction: The combination of lithium and valproate is the most recommended treatment for relapse prevention in Bipolar Affective Disorder (BPAD) after the failure of monotherapy. If it is proven that functioning, quality of life and cognitive functioning in bipolar patients on a sodium valproate and lithium combination are better than those on valproate monotherapy, this could further encourage the use of combination therapy. Aim: To compare the functioning, quality of life and cognitive functioning of euthymic bipolar patients on lithium and sodium valproate combination therapy with those on sodium valproate monotherapy. Materials and Methods: The present hospital-based cross-sectional study was conducted in the Outpatient Department, Institute of Mental Health, Madras Medical College, Chennai, Tamil Nadu, India, from March 2017 to July 2017. A total of 80 patients were included in the study. Forty euthymic bipolar disorder patients on a lithium and sodium valproate combination for at least a year were chosen as group 1. Forty euthymic bipolar patients on sodium valproate monotherapy for at least a year were chosen as group 2. Socio-demographic details and clinical characteristics of both groups were collected. The Global Assessment of Functioning (GAF) scale and the World Health Organisation Quality of Life Brief (WHOQoL-BREF) version scale were applied to both groups. Cognitive assessment using the Frontal Assessment Battery (FAB), Trail Making Test-A (TMT-A) and Trail Making Test-B (TMT-B) was conducted. Statistical analysis was performed using International Business Machines (IBM) Statistical Package for Social Sciences (SPSS) software version 20.0. An independent t-test was used to compare quality of life and cognitive variables, as well as, the number of episodes post-treatment between the two groups. A Chi-square test was used to compare functioning between the two groups. Results: The mean±Standard Deviation (SD) age of onset in group 1 was 26.73±5.77 years and in group 2 was 27.03±6.49 years. There were 22 (55%) males and 18 (45) females in group 1 and, 20 (50) males and 20 (50) females in group 2. There were no statistical differences in socio-demographic characteristics between both groups (p-value>0.05). Functioning and quality of life were significantly better in the combination therapy group (p-value ≤0.01). Cognitive variables like FAB score, and time taken to complete TMT-A and TMT-B in seconds showed no significant differences (p-value>0.05). By independent t-test, the reduction in episodes of bipolar illness after treatment was found to be greater in group 1 (p-value=0.006). Conclusion: The functioning, quality of life and effectiveness of treatment for those euthymic bipolar patients on lithium and sodium valproate combination therapy were found to be better than those on valproate monotherapy alone. There was no significant change in cognitive functioning between the two groups.https://jcdr.net/articles/PDF/20524/74880_CE[Ra1]_F(SHU)_QC(AN_OM)_PF1(JY_SS)_PFA(IS)_PB(JY_IS)_PN(IS).pdffrontal assessment batteryglobal assessment of functioningmajor depressive disordermaniatrail making testyoung mania rating scale
spellingShingle M Ashwini
R Jhamuna
V Jaikumar
Comparison of Functioning, Quality of Life, and Cognition between Lithium and Sodium Valproate Combination Therapy and Sodium Valproate Monotherapy in Euthymic Bipolar Patients: A Cross-sectional Study
Journal of Clinical and Diagnostic Research
frontal assessment battery
global assessment of functioning
major depressive disorder
mania
trail making test
young mania rating scale
title Comparison of Functioning, Quality of Life, and Cognition between Lithium and Sodium Valproate Combination Therapy and Sodium Valproate Monotherapy in Euthymic Bipolar Patients: A Cross-sectional Study
title_full Comparison of Functioning, Quality of Life, and Cognition between Lithium and Sodium Valproate Combination Therapy and Sodium Valproate Monotherapy in Euthymic Bipolar Patients: A Cross-sectional Study
title_fullStr Comparison of Functioning, Quality of Life, and Cognition between Lithium and Sodium Valproate Combination Therapy and Sodium Valproate Monotherapy in Euthymic Bipolar Patients: A Cross-sectional Study
title_full_unstemmed Comparison of Functioning, Quality of Life, and Cognition between Lithium and Sodium Valproate Combination Therapy and Sodium Valproate Monotherapy in Euthymic Bipolar Patients: A Cross-sectional Study
title_short Comparison of Functioning, Quality of Life, and Cognition between Lithium and Sodium Valproate Combination Therapy and Sodium Valproate Monotherapy in Euthymic Bipolar Patients: A Cross-sectional Study
title_sort comparison of functioning quality of life and cognition between lithium and sodium valproate combination therapy and sodium valproate monotherapy in euthymic bipolar patients a cross sectional study
topic frontal assessment battery
global assessment of functioning
major depressive disorder
mania
trail making test
young mania rating scale
url https://jcdr.net/articles/PDF/20524/74880_CE[Ra1]_F(SHU)_QC(AN_OM)_PF1(JY_SS)_PFA(IS)_PB(JY_IS)_PN(IS).pdf
work_keys_str_mv AT mashwini comparisonoffunctioningqualityoflifeandcognitionbetweenlithiumandsodiumvalproatecombinationtherapyandsodiumvalproatemonotherapyineuthymicbipolarpatientsacrosssectionalstudy
AT rjhamuna comparisonoffunctioningqualityoflifeandcognitionbetweenlithiumandsodiumvalproatecombinationtherapyandsodiumvalproatemonotherapyineuthymicbipolarpatientsacrosssectionalstudy
AT vjaikumar comparisonoffunctioningqualityoflifeandcognitionbetweenlithiumandsodiumvalproatecombinationtherapyandsodiumvalproatemonotherapyineuthymicbipolarpatientsacrosssectionalstudy